Business Wire | Oct 29, 2020 05:00PM EDT

Aptar Reports Third Quarter 2020 Results

Oct. 29, 2020

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Oct. 29, 2020--AptarGroup, Inc. (NYSE:ATR) today reported third quarter results for 2020 and provided an update related to COVID-19 including the Company's continued supply of essential products for critical industries.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201029006225/en/

Photo: Aptar's Corporate Headquarters in Crystal Lake, IL

Third Quarter 2020 Summary

* Reported sales increased 8%, including positive effects of currency translation rates and recent acquisitions, and core sales increased 2% * Strong reported and core growth in our Pharma segment * Core sales growth in the food, personal care and home care markets * Sales to the beauty and beverage markets continue to be impacted by COVID-19 pandemic * Recent acquisitions are performing well * Reported earnings per share totaled $0.95 (an increase of 12% compared to the prior year) * Adjusted earnings per share totaled $1.00 (an increase of 3% compared to the prior year) * Reported net income totaled $64 million (an increase of 12% compared to the prior year) * Adjusted EBITDA totaled $157 million (an increase of 7% compared to the prior year) * Cash flow from operations was $381 million in the first nine months of 2020 (a slight increase over the prior year) * Free cash flow was $208 million in the first nine months of 2020 (an increase of 8% compared to the prior year) * Declared quarterly dividend of $0.36 per share

COVID-19 Update

"As we continue to rigorously monitor the ongoing COVID-19 situation across the globe, our priorities remain the health and safety of our employees and continued production for our customers," said Stephan Tanda, Aptar President and CEO. "Millions of people around the world rely on Aptar solutions to dispense the medicines and products they need and we are delivering on our promises to our customers." During the pandemic, we have continuously adapted our safety and cleaning procedures and remote working protocols in accordance with the legislation or regulations applicable to each of our facilities.

Third Quarter Results

For the quarter ended September 30, 2020, reported sales increased 8% to $759 million compared to $701 million in the prior year. Core sales, excluding the impacts from changes in currency exchange rates and acquisitions, increased approximately 2%.

Third Quarter Segment Sales Analysis(Change Over Prior Year) Beauty + Pharma Food + Total Home Beverage AptarGroupCore Sales Growth (5%) 11% 2% 2%

Acquisitions 7% 2% 0% 4%

Currency Effects ^(1) 1% 4% 0% 2%

Total Reported Sales Growth 3% 17% 2% 8%

(1) - Currency effects are approximated by translating last year's amounts atthis year's foreign exchange rates. Commenting on the quarter, Tanda said, "Overall, we had a very good quarter that speaks to the resilience of our diverse and growing end markets. Our Pharma segment reported impressive growth compared to a strong quarter a year ago. This was in part due to solid underlying demand for existing medicines during the pandemic, such as influenza vaccines, and allergy and asthma treatments, that are administered using our drug delivery devices and components for injection systems. We also performed well in other markets and grew core sales in the food, personal care and home care markets. Collectively this drove top line and earnings per share growth despite the challenges posed by the pandemic." Aptar's Pharma segment experienced increased broad-based demand with particularly strong growth in our injectables and active packaging divisions. Sales of consumer health care and prescription drug delivery devices increased over a particularly strong quarter a year ago. Aptar's Beauty + Home segment benefitted from strong sales to the personal care market related to hand sanitizers and liquid soaps and increased sales to the home care market primarily related to cleaners and disinfectants. Sales to the beauty market continued to be negatively impacted by the effects of COVID-19. Aptar's Food + Beverage segment reported positive sales growth with strong sales to the food market due to the demand for pantry staples with consumers continuing to cook at home during the pandemic. Sales to the beverage market continued to be impacted by lower demand for on-the-go beverages related to the pandemic. In addition, the effects of passing through lower resin prices to customers also affected the segment's overall growth.

Aptar reported third quarter earnings per share of $0.95 compared to $0.85 during the same period a year ago, an increase of 12%. Current year adjusted earnings per share, excluding restructuring expenses and acquisition-related costs, were $1.00 and increased 3% from the prior year adjusted earnings per share, including comparable exchange rates, of $0.97.

Year-to-Date Results

For the nine months ended September 30, 2020, reported sales of $2.18 billion were in line with $2.19 billion reported a year ago. The core sales decline of 2% and the negative effects of currency translation rates were offset by the positive contribution from acquisitions.

Nine Months Year-to-Date Segment Sales Analysis(Change Over Prior Year) Beauty + Pharma Food + Total Home Beverage AptarGroupCore Sales Growth (9%) 8% (5%) (2%)

Acquisitions 4% 3% 0% 3%

Currency Effects ^(1) (2%) 0% (2%) (1%)

Total Reported Sales Growth (7%) 11% (7%) 0%

(1) - Currency effects are approximated by translating last year's amounts atthis year's foreign exchange rates. Tanda commented on the year-to-date results, "Our Pharma segment continued to perform very well through the first nine months of the year on top of a very strong period a year ago. Our Beauty + Home and Food + Beverage segments experienced a more difficult first nine months due to the impacts of COVID-19. However, we saw progressive signs of improvement for Beauty + Home and positive results for Food + Beverage as we moved further into the year. We are also very pleased with the performance of our recent acquisitions, in particular FusionPKG and Noble."

For the nine months year-to-date, Aptar's reported earnings per share were $2.42, and down 17%, compared to $2.93 reported a year ago. Current year adjusted earnings per share, which exclude restructuring costs and acquisition-related expenses, were $2.72 and down 14% from prior year adjusted earnings per share, including comparable exchange rates, of $3.15.

Strong Cash Flow

Cash generated from operations for the nine months year-to-date reached $381 million and was a slight improvement over the prior year primarily due to better working capital management. The company generated $208 million of free cash flow (cash flow from operations less capital expenditures) for the first nine months of 2020, an increase of 8% over $194 million in the prior year. Tanda commented, "We continue to generate free cash flow above the prior year levels which is a testament to our resilient business, especially during difficult economic conditions."

Outlook

"We expect the company to continue to achieve core sales growth in the fourth quarter. Rising demand in many end markets is expected to more than offset COVID-19 related declines in some of our other end markets. We are proud of the way our employees have responded to the difficult year and we are performing well. We expect our Pharma business to continue to do well with existing business and increased opportunities directly and indirectly related to the pandemic," said Tanda.

Aptar expects earnings per share for the fourth quarter of 2020, excluding any restructuring expenses and acquisition-related costs, to be in the range of $0.84 to $0.92. This guidance is based on an effective tax rate range of 27% to 29%.

Cash Dividend

As previously announced, the Board declared a quarterly cash dividend of $0.36 per share. The payment date is November 18, 2020, to stockholders of record as of October 28, 2020.

Open Conference Call

There will be a conference call on Friday, October 30, 2020 at 8:00 a.m. Central Time to discuss the Company's third quarter results for 2020. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investor Relations page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investor Relations page of the website.

About Aptar

Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active packaging solutions. Aptar uses insights, design, engineering and science to create dosing, dispensing and protective technologies for the world's leading brands, in turn making a meaningful difference in the lives, looks, health and homes of millions of people around the world. Aptar's innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage. Aptar is headquartered in Crystal Lake, Illinois and has 14,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.

Presentation of Non-GAAP Information

This press release refers to certain non-GAAP financial measures, including current year adjusted earnings per share and adjusted EBITDA, which exclude the impact of business transformation charges (restructuring initiatives), acquisition-related expenses and certain purchase accounting adjustments related to acquisitions and investments. Core sales and adjusted earnings per share also neutralize the impact of foreign currency translation effects when comparing current results to the prior year. Non-GAAP financial measures may not be comparable to similarly titled non-GAAP financial measures provided by other companies. Aptar's management believes these non-GAAP financial measures provide useful information to our investors because they allow for a better period over period comparison of operating results by removing the impact of items that, in management's view, do not reflect Aptar's core operating performance. These non-GAAP financial measures also provide investors with certain information used by Aptar's management when making financial and operational decisions. Free cash flow is calculated as cash provided by operating activities less capital expenditures. We use free cash flow to measure cash flow generated by operations that is available for dividends, share repurchases, acquisitions and debt repayment. We believe that it is meaningful to investors in evaluating our financial performance and measure our ability to generate cash internally to fund our initiatives. These non-GAAP financial measures should not be considered in isolation or as a substitute for GAAP financial results but should be read in conjunction with the unaudited condensed consolidated statements of income and other information presented herein. A reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures is included in the accompanying tables. Our outlook is provided on a non-GAAP basis because certain reconciling items are dependent on future events that either cannot be controlled, such as exchange rates, or reliably predicted because they are not part of the Company's routine activities, such as restructuring and acquisition costs.

This press release contains forward-looking statements, including certain statements set forth under the "Outlook" section of this press release and statements regarding the anticipated impact of the COVID-19 pandemic. Words such as "expects," "anticipates," "believes," "estimates," "future," "potential" and other similar expressions or future or conditional verbs such as "will," "should," "would" and "could" are intended to identify such forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on our beliefs as well as assumptions made by and information currently available to us. Accordingly, our actual results or other events may differ materially from those expressed or implied in such forward-looking statements due to known or unknown risks and uncertainties that exist in our operations and business environment including, but not limited to: outbreaks of pandemics, including the impact of the COVID-19 pandemic on our global supply chain and our global customers and operations; the successful integration of acquisitions and the achievement of the expected benefits of acquisitions and investments; the impact of tax reform legislation including changes in tax rates and other tax-related events or transactions that could impact our effective tax rate; the execution of the business transformation plan; economic conditions worldwide including potential deflationary or inflationary conditions or economic downturn or uncertainty in regions we rely on for growth as a result of the COVID-19 pandemic or otherwise; political conditions worldwide; significant fluctuations in foreign currency exchange rates; changes in customer and/or consumer spending levels; financial conditions of customers and suppliers; consolidations within our customer or supplier bases; fluctuations in the cost of materials, components and other input costs; the availability of raw materials and components; our ability to successfully implement facility expansions and new facility projects; our ability to increase prices, contain costs and improve productivity; changes in capital availability or cost, including interest rate fluctuations; volatility of global credit markets; cybersecurity threats that could impact our networks and reporting systems; fiscal and monetary policies and other regulations; direct or indirect consequences of acts of war or terrorism; and work stoppages due to labor disputes. For additional information on these and other risks and uncertainties, please see our filings with the Securities and Exchange Commission, including the discussion under "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Form 10-K and Form 10-Qs. We undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

AptarGroup, Inc.Condensed Consolidated Financial Statements (Unaudited)(In Thousands, Except Per Share Data)Consolidated Statements of Income Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019

Net Sales $ 759,153 $ 701,278 $ 2,180,011 $ 2,188,399

Cost of Sales(exclusive of 479,672 444,237 1,372,630 1,382,810 depreciation and amortization shownbelow)Selling, Research & 121,850 111,559 371,407 346,526 Development and AdministrativeDepreciation and 55,179 49,218 162,414 144,574 AmortizationRestructuring 3,415 6,019 15,585 17,286 InitiativesOperating Income 99,037 90,245 257,975 297,203

Other Income/ (Expense):Interest Expense (8,851 ) (8,898 ) (25,973 ) (26,868 )

Interest Income 249 957 599 3,738

Equity in Results of (256 ) 238 (1,383 ) 152 AffiliatesMiscellaneous, net (1,040 ) (269 ) (3,375 ) 148

Income before Income 89,139 82,273 227,843 274,373 TaxesProvision for Income 25,404 25,504 66,998 80,684 TaxesNet Income $ 63,735 $ 56,769 $ 160,845 $ 193,689

Net IncomeAttributable to (19 ) (19 ) (37 ) (20 )NoncontrollingInterestsNet Income $ 63,716 $ 56,750 $ 160,808 $ 193,669 Attributable to AptarGroup, Inc.Net IncomeAttributable to AptarGroup, Inc. perCommon Share:Basic $ 0.99 $ 0.89 $ 2.50 $ 3.05

Diluted $ 0.95 $ 0.85 $ 2.42 $ 2.93

Average Numbers of Shares Outstanding:Basic 64,562 64,010 64,278 63,485

Diluted 66,922 66,702 66,483 66,163

AptarGroup, Inc.Condensed Consolidated Financial Statements (Unaudited)(continued)($ In Thousands)Consolidated Balance Sheets September 30, December 31, 2020 2019ASSETS Cash and Equivalents $ 226,546 $ 241,970

Receivables, net 593,418 558,428

Inventories 375,177 375,795

Other Current Assets 132,055 115,048

Total Current Assets 1,327,196 1,291,241

Net Property, Plant and Equipment 1,139,899 1,087,678

Goodwill 878,015 763,461

Other Assets 516,639 419,739

Total Assets $ 3,861,749 $ 3,562,119

LIABILITIES AND EQUITY Short-Term Obligations $ 161,256 $ 110,247

Accounts Payable, Accrued and Other 625,865 573,028LiabilitiesTotal Current Liabilities 787,121 683,275

Long-Term Obligations 1,039,935 1,085,453

Deferred Liabilities 274,738 221,139

Total Liabilities 2,101,794 1,989,867

AptarGroup, Inc. Stockholders' Equity 1,759,572 1,571,916

Noncontrolling Interests in Subsidiaries 383 336

Total Equity 1,759,955 1,572,252

Total Liabilities and Equity $ 3,861,749 $ 3,562,119

AptarGroup, Inc.Reconciliation of Adjusted EBIT and Adjusted EBITDA to Net Income (Unaudited)($ In Thousands) Three Months Ended September 30, 2020 Consolidated Beauty + Pharma Food + Corporate & Net Home Beverage Other InterestNet Sales $ 759,153 337,231 315,758 106,164 - -

Reported net $ 63,735 incomeReported 25,404 income taxesReported 89,139 7,944 92,202 10,884 (13,289 ) (8,602 )income beforeincome taxesAdjustments:Restructuring 3,415 3,144 300 (31 ) 2 initiativesTransactioncosts related 221 11 210 toacquisitionsAdjustedearnings 92,775 11,099 92,712 10,853 (13,287 ) (8,602 )before incometaxesInterest 8,851 8,851 expenseInterest (249 ) (249 )incomeAdjustedearningsbefore net 101,377 11,099 92,712 10,853 (13,287 ) - interest andtaxes(AdjustedEBIT)Depreciation 55,179 23,634 19,724 9,498 2,323 - andamortizationAdjustedearningsbefore netinterest,taxes, $ 156,556 $ 34,733 $ 112,436 $ 20,351 $ (10,964 ) $ - depreciationandamortization(AdjustedEBITDA) AdjustedEBITDAmargins 20.6 % 10.3 % 35.6 % 19.2 %(AdjustedEBITDA /Reported NetSales) Three Months Ended September 30, 2019 Consolidated Beauty + Pharma Food + Corporate & Net Home Beverage Other InterestNet Sales $ 701,278 328,182 269,251 103,845 - -

Reported net $ 56,769 incomeReported 25,504 income taxesReported 82,273 15,413 78,418 9,323 (12,940 ) (7,941 )income beforeincome taxesAdjustments:Restructuring 6,019 5,341 168 204 306 initiativesTransactioncosts related 708 34 520 154 toacquisitionsPurchaseaccountingadjustments 647 647 related toacquisitionsandinvestmentsAdjustedearnings 89,647 20,788 79,753 9,681 (12,634 ) (7,941 )before incometaxesInterest 8,898 8,898 expenseInterest (957 ) (957 )incomeAdjustedearningsbefore net 97,588 20,788 79,753 9,681 (12,634 ) - interest andtaxes(AdjustedEBIT)Depreciation 49,218 20,687 16,793 9,047 2,691 - andamortizationPurchaseaccountingadjustmentsincluded in (647 ) (647 )DepreciationandamortizationaboveAdjustedearningsbefore netinterest,taxes, $ 146,159 $ 41,475 $ 95,899 $ 18,728 $ (9,943 ) $ - depreciationandamortization(AdjustedEBITDA) AdjustedEBITDAmargins 20.8 % 12.6 % 35.6 % 18.0 %(AdjustedEBITDA /Reported NetSales)AptarGroup, Inc.Reconciliation of Adjusted EBIT and Adjusted EBITDA to Net Income (Unaudited)($ In Thousands) Nine Months Ended September 30, 2020 Consolidated Beauty + Pharma Food + Corporate & Net Home Beverage Other InterestNet Sales $ 2,180,011 961,577 914,213 304,221 - -

Reported net $ 160,845 incomeReported 66,998 income taxesReported 227,843 2,297 267,523 25,365 (41,968 ) (25,374 )income beforeincome taxesAdjustments:Restructuring 15,585 15,375 158 147 (95 )initiativesTransactioncosts related 4,812 4,602 210 toacquisitionsPurchaseaccountingadjustments 4,642 3,221 1,421 related toacquisitionsandinvestmentsAdjustedearnings 252,882 25,495 269,312 25,512 (42,063 ) (25,374 )before incometaxesInterest 25,973 25,973 expenseInterest (599 ) (599 )incomeAdjustedearningsbefore net 278,256 25,495 269,312 25,512 (42,063 ) - interest andtaxes(AdjustedEBIT)Depreciation 162,414 70,159 56,232 28,031 7,992 - andamortizationPurchaseaccountingadjustmentsincluded in (3,367 ) (2,700 ) (667 )DepreciationandamortizationaboveAdjustedearningsbefore netinterest,taxes, $ 437,303 $ 92,954 $ 324,877 $ 53,543 $ (34,071 ) $ - depreciationandamortization(AdjustedEBITDA) AdjustedEBITDAmargins 20.1 % 9.7 % 35.5 % 17.6 %(AdjustedEBITDA /Reported NetSales) Nine Months Ended September 30, 2019 Consolidated Beauty + Pharma Food + Corporate & Net Home Beverage Other InterestNet Sales $ 2,188,399 1,037,921 823,891 326,587 - -

Reported net $ 193,689 incomeReported 80,684 income taxesReported 274,373 66,407 244,101 29,234 (42,239 ) (23,130 )income beforeincome taxesAdjustments:Restructuring 17,286 14,869 381 826 1,210 initiativesTransactioncosts related 1,767 34 1,579 154 toacquisitionsPurchaseaccountingadjustments 869 869 related toacquisitionsandinvestmentsAdjustedearnings 294,295 81,310 246,930 30,214 (41,029 ) (23,130 )before incometaxesInterest 26,868 26,868 expenseInterest (3,738 ) (3,738 )incomeAdjustedearningsbefore net 317,425 81,310 246,930 30,214 (41,029 ) - interest andtaxes(AdjustedEBIT)Depreciation 144,574 62,101 48,623 26,149 7,701 - andamortizationPurchaseaccountingadjustmentsincluded in (869 ) (869 )DepreciationandamortizationaboveAdjustedearningsbefore netinterest,taxes, $ 461,130 $ 143,411 $ 294,684 $ 56,363 $ (33,328 ) $ - depreciationandamortization(AdjustedEBITDA) AdjustedEBITDAmargins 21.1 % 13.8 % 35.8 % 17.3 %(AdjustedEBITDA /Reported NetSales) AptarGroup, Inc.Reconciliation of Adjusted Earnings Per Diluted Share (Unaudited)(In Thousands, Except Per Share Data) Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019

Income before Income Taxes $ 89,139 $ 82,273 $ 227,843 $ 274,373

Adjustments:Restructuring initiatives 3,415 6,019 15,585 17,286

Transaction costs related to 221 708 4,812 1,767 acquisitionsPurchase accounting adjustments - 647 4,642 869 related to acquisitions andinvestmentsForeign currency effects (1) 3,650 302

Adjusted Earnings before Income $ 92,775 $ 93,297 $ 252,882 $ 294,597 Taxes Provision for Income Taxes $ 25,404 $ 25,504 $ 66,998 $ 80,684

Adjustments:Restructuring initiatives 598 1,691 3,304 4,857

Transaction costs related to 25 101 713 154 acquisitionsPurchase accounting adjustments - 123 1,026 165 related to acquisitions andinvestmentsForeign currency effects (1) 1,132 89

Adjusted Provision for Income $ 26,027 $ 28,551 $ 72,041 $ 85,949 Taxes Net Income Attributable to $ (19 ) $ (19 ) $ (37 ) $ (20 )Noncontrolling Interests Net Income Attributable to $ 63,716 $ 56,750 $ 160,808 $ 193,669 AptarGroup, Inc. Adjustments:Restructuring initiatives 2,817 4,328 12,281 12,429

Transaction costs related to 196 607 4,099 1,613 acquisitionsPurchase accounting adjustments - 524 3,616 704 related to acquisitions andinvestmentsForeign currency effects (1) 2,518 213

Adjusted Net Income Attributable $ 66,729 $ 64,727 $ 180,804 $ 208,628 to AptarGroup, Inc. Average Number of Diluted Shares 66,922 66,702 66,483 66,163 Outstanding Net Income Attributable to $ 0.95 $ 0.85 $ 2.42 $ 2.93 AptarGroup, Inc. Per DilutedShare Adjustments:Restructuring initiatives 0.05 0.06 0.19 0.19

Transaction costs related to - 0.01 0.06 0.02 acquisitionsPurchase accounting adjustments - 0.01 0.05 0.01 related to acquisitions andinvestmentsForeign currency effects (1) 0.04 -

Adjusted Net Income Attributable $ 1.00 $ 0.97 $ 2.72 $ 3.15 to AptarGroup, Inc. Per DilutedShare (1) Foreign currency effects are approximations of the adjustment necessary tostate the prior year earnings and earnings per share using current periodforeign currency exchange rates.AptarGroup, Inc.Reconciliation of Free Cash Flow to Net Cash Provided by Operations (Unaudited)(In Thousands) Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019

Net Cash Provided by Operations $ 153,741 $ 159,241 $ 381,427 $ 380,381

Less:Capital Expenditures $ 50,379 $ 62,067 $ 173,365 $ 186,841

Free Cash Flow $ 103,362 $ 97,174 $ 208,062 $ 193,540

AptarGroup, Inc.Reconciliation of Adjusted Earnings Per Diluted Share (Unaudited)(In Thousands, Except Per Share Data) Three Months Ending December 31, Expected 2019 2020 Income before Income Taxes $ 67,696

Adjustments:Restructuring initiatives 3,186

Transaction costs related to acquisitions 2,160

Purchase accounting adjustments related to acquisitions 333 and investmentsForeign currency effects (1) 4,236

Adjusted Earnings before Income Taxes $ 77,611

Provision for Income Taxes $ 19,158

Adjustments:Restructuring initiatives 895

Transaction costs related to acquisitions 379

Purchase accounting adjustments related to acquisitions 53 and investmentsForeign currency effects (1) 1,199

Adjusted Provision for Income Taxes $ 21,684

Net Income Attributable to Noncontrolling Interests $ (5 )

Net Income Attributable to AptarGroup, Inc. $ 48,533

Adjustments:Restructuring initiatives 2,291

Transaction costs related to acquisitions 1,781

Purchase accounting adjustments related to acquisitions 280 and investmentsForeign currency effects (1) 3,037

Adjusted Net Income Attributable to AptarGroup, Inc. $ 55,922

Average Number of Diluted Shares Outstanding 66,192

Net Income Attributable to AptarGroup, Inc. Per Diluted $ 0.73 Share (2) Adjustments:Restructuring initiatives 0.03

Transaction costs related to acquisitions 0.03

Purchase accounting adjustments related to acquisitions 0.01 and investmentsForeign currency effects (1) 0.04

Adjusted Net Income Attributable to AptarGroup, Inc. $0.84 - $ 0.84 Per Diluted Share (2) $0.92 (1) Foreign currency effects are approximations of the adjustment necessary tostate the prior year earnings per share using foreign currency exchange ratesas of September 30, 2020.(2) AptarGroup's expected earnings per share range for the fourth quarter of2020 is based on an effective tax rate range of 27% to 29%. This tax rate rangecompares to our fourth quarter of 2019 effective tax rate of 28% on reportedand adjusted earnings per share. View source version on businesswire.com: https://www.businesswire.com/news/home/20201029006225/en/

CONTACT: Investor Relations Contact: Matt DellaMaria matt.dellamaria@aptar.com 815-479-5530 Media Contact: Katie Reardon katie.reardon@aptar.com 815-479-5671